Register to get unlimited access to our investor forum and all editorial content, including our e-zine and weekly email. Registration is free and only takes a minute.

Comment & Analysis

Pershing Square: buying opportunity or value trap?

Has hedge fund manager Bill Ackman got what it takes to improve performance of Pershing Square Holdings following its move to London?

Stifel: our two favourite biotech trusts

Stifel analyst Anthony Stern says a buying opportunity remains in biotechnology as investors worry unnecessarily about US government action on drug prices.

Can Invesco Asia break its discount cycle?

Invesco Asia hopes a tender offer to buy back 15% of its shares will narrow the trust's persistent discount, but commentators fear it could be caught in a vicious circle.

Ian Cowie: why ‘little Englanders’ should take note of Europe’s bounce

European investment trusts are rallying as receding political risk makes their markets look cheap. One more setback could make the UK good value too.

Investment Trust Watch: poorly Patient Capital looks 'cheap'

Shares in Woodford Patient Capital fell to their biggest-ever discount this week, as early-stage investment trust continues to languish.

Barry Olliff: the City’s bonus culture must change if we are all to prosper

The City’s relentless focus on personal gain promotes culture of greed and excessive risk taking, says leading investor in investment trusts.

James Carthew: Brexit isn’t all bad news for UK property

Results from TR Property and other real estate trusts enable us to take the pulse of commercial property a year after EU referendum.

Investment Trust Watch: soaring Syncona cures worries

Shares in Syncona soar to double-digit premium, allaying fears over former Battle Against Cancer trust's overhaul.

Ian Cowie: power to The People’s Trust’s new managers but is proposition right?

Daniel Godfrey, former director general of Association of Investment Companies, unveils five managers for The People’s Trust in September.

James Carthew: time for Aberdeen to deliver on Diversified Income

The reorganisation of Aberdeen Diversified Income & Growth, formerly known as BlackRock Income Strategies, is nearly complete. Will it do better than previous incarnations?